- Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Academic Article GET IT
Single-cell copy number analysis of prostate cancer cells captured with geometrically enhanced differential immunocapture microdevices.
Times cited: 2
- Parallelized microfluidic immuno capture of circulating pancreatic cells for genetic analysis and early detection of pancreatic carcinogenesis. 2013 Conference Paper
- Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device. PloS one. 2012 Academic Article GET IT
- Circulating tumor cell release by use of novel immunocapture chemistry in gedi microdevices. 2011 Conference Paper
- Functional assays of drug-target engagement on circulating tumor cells captured from patient blood correlate with patient progression. 2011 Conference Paper
Rare Cell Capture in Microfluidic Devices.
Chemical engineering science.
Times cited: 110
- Cancer cell assays by use of immunocapture, subcellular imaging, and programmed cell release in gedi microdevices. 2010 Conference Paper
- Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody. Lab on a chip. 2010 Academic Article GET IT
- High efficiency capture of circulating tumor cells from patient blood using geometrically-enhanced differential immunocapture. 2009 Conference Paper